title: Hypertensive-diabetic cardiomyopathy in rats.
abstract: Left ventricular papillary muscle function, transmembrane action potentials, myosin adenosinetriphosphatase (ATPase) and isoenzyme distribution, and myocardial pathology were studied in hypertensive (H), diabetic (D), hypertensive-diabetic (HD), and control (C) rats. There was approximately 50% relative left ventricular hypertrophy in H and HD rats. Relative lung and liver weights were greater in HD rats. Peak velocity of shortening tended to decrease progressively in H, D, and HD rats. The duration of contraction and relaxation was markedly prolonged in Ds and HDs. The length-developed tension relation was blunted in HDs. The negative inotropic effect of verapamil was similar in all groups. Resting membrane potential and amplitude were decreased in D and HD rats. Action potential duration was increased in H, D, and especially HD rats. The shortening of action potential duration with increased stimulus frequency was greater in H, D, and especially HD rats than in Cs. Left ventricular myosin ATPase and V1 isoenzyme content decreased progressively in H, D, and HD rats. Right ventricular V1 isoenzyme content was not affected in H rats but was markedly decreased in D and HD rats. Left (and right) ventricular pathology was unchanged in rats with diabetes but was increased in rats with hypertension. These data suggest that the combination of myocardial pathology (due to hypertension) and cellular dysfunction (caused mainly by diabetes) may result in cardiomyopathy and congestive heart failure in the HD rat.
authors: Department of Medicine, Albert Einstein College of Medicine, Bronx, New York.
authors: F S
authors: FS
authors: Fein
authors: B E
authors: BE
authors: Zola
authors: A
authors: A
authors: Malhotra
authors: S
authors: S
authors: Cho
authors: S M
authors: SM
authors: Factor
authors: J
authors: J
authors: Scheuer
authors: E H
authors: EH
authors: Sonnenblick
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001696:Biomechanical Phenomena; D009202:Cardiomyopathies / Q000209:etiology* / Q000473:pathology; D003285:Contractile Proteins / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000150:complications* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004594:Electrophysiology; D005260:Female; D006352:Heart Ventricles; D006973:Hypertension / Q000150:complications* / Q000503:physiopathology; D007537:Isometric Contraction; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D010210:Papillary Muscles / Q000187:drug effects / Q000503:physiopathology; D051381:Rats; D011919:Rats, Inbred Strains; D013311:Streptozocin; D014700:Verapamil / Q000494:pharmacology
chemical_list: D003285:Contractile Proteins; D013311:Streptozocin; D014700:Verapamil